Real-time enrollment status for this autism spectrum disorder clinical trial
Current Status
Completed
Checked: June 1, 2026 at 8:31 PM UTC
| NCT Number | NCT05081245 |
| Recruiting Status | Completed |
| Condition | Autism Spectrum Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 33 sites in the US |
| Sponsor | MapLight Therapeutics |
| Last Updated on CT.gov | May 19, 2026 (1 week ago) |
As of June 1, 2026: Clinical trial NCT05081245 is currently completed participants. This clinical trial study for autism spectrum disorder is not currently accepting new participants at 33 locations across the United States. The study is sponsored by MapLight Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05081245 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05081245 was last updated 1 week ago (May 19, 2026). HelloStudys verifies this status automatically.